🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

I will be a participant at Digital #LiverCancerSummit 2021. Join me there to discuss the latest knowledge on #livercancer. Together we are stronger against liver cancer. Find out more about the event: bit.ly/dlcs2021 EASLnews

p53-independent induction of p21 fails to control regeneration and hepatocarcinogenesis in a murine liver injury model cmghjournal.org/article/S2352-…

The co‐mutational spectrum determines the therapeutic response in murine FGFR2 fusion ‐ driven cholangiocarcinoma aasldpubs.onlinelibrary.wiley.com/doi/abs/10.100…

#News: The European Commission has granted approval for a new treatment for adults with locally advanced or metastatic #cholangiocarcinoma with FGFR2 fusion or rearrangement that have progressed after at least one prior line of systemic therapy.

Outstanding work by Dr. Czauderna highlighting the importance of early epigenetic alterations in HCC. Thanks to everybody for the great contribution Jesper B Andersen Colm O'Rourke insight.jci.org/articles/view/…

#ascogi22 Great presentation by Augusto Villanueva @augustoNYC and many others on primary liver cancer. Practice Changing results from TOPAZ-1 in #BiliaryTractCancer and HIMALAYA #HCC later today.

Liver Cancer Summit 2022 easl.eu/event/liver-ca…

Great work by Lichun Ma and Xin Wei Wang dissecting intratumoral heterogeneity of primary liver cancer nature.com/articles/s4146…

Herzliche Einladung zu unserem 4. Ostseesymposium der Viszeralonkologie! ostsee-symposium.org